Explore the critical importance of early detection in combating Alzheimer's disease in this 14-minute TEDx talk by Dr. Daniel Seichepine. Learn why Alzheimer's is considered a mid-life disease despite its later-life manifestations, and discover the potential of newly FDA-approved medication in reducing harmful brain plaques. Gain insights from Dr. Seichepine, a clinical neuropsychologist and associate professor specializing in aging and neurological disorders, as he emphasizes the power of early intervention in preventing plaque formation. Understand the latest developments in Alzheimer's research and treatment, drawing from Dr. Seichepine's extensive experience in neurodegenerative disorders and his work in medication development for Alzheimer's and Parkinson's diseases.